2001 Mar;33(3):205-20.
Briggs R, McCarroll K, OHalloran A, Healy M, Kenny RA, Laird E
A 2023 observational study of 47 patients using both agent classes reported modest synergistic weight loss (additional 35 lbs over 12 weeks compared to single-agent) but also a 34% incidence of nausea, dizziness, or appetite suppression beyond baseline tirzepatide side effects
(a-v-a-viii) After 90 min oxygen-glucose deprivation, cells were incubated with normal medium containing (25 mM glucose) and 21 % O2 for different reperfusion time, 30 min (a-v), 60 min (a-vi), 90 min (a-vii), 120 min (a-viii), subsequent, LJ-GSH (10 M) were added to cells for another 30 min incubation
Yang M, Chan HW, Yu LC